Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LISURIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 73 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Stocchi, F; Vacca, L; Berardelli, A; De Pandis, F; Ruggieri, S
      Long-duration effect and the postsynaptic compartment: Study using a dopamine agonist with a short half-life

      MOVEMENT DISORDERS
    2. Jankovic, J; Tan, EK
      Choosing dopamine agonists in Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    3. Reuter, M; Netter, P
      The influence of personality on nicotine craving: A hierarchical multivariate statistical prediction model

      NEUROPSYCHOBIOLOGY
    4. Kaleli, S; Aydin, Y; Erel, CT; Colgar, U
      Symptomatic treatment of premenstrual mastalgia in premenopausal women with lisuride maleate: a double-blind placebo-controlled randomized study

      FERTILITY AND STERILITY
    5. Contin, M; Riva, R; Albani, F; Baruzzi, A
      Pharmacokinetic optimisation of dopamine receptor agonist therapy for Parkinson's disease

      CNS DRUGS
    6. Wolffgramm, J; Galli, G; Thimm, F; Heyne, A
      Animal models of addiction: models for therapeutic strategies?

      JOURNAL OF NEURAL TRANSMISSION
    7. Allain, H; Destee, A; Petit, H; Patay, M; Schuck, S; Bentue-Ferrer, D; Le Cavorzin, P
      Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease

      EUROPEAN NEUROLOGY
    8. Colosimo, C; De Michele, M
      Motor fluctuations in Parkinson's disease: pathophysiology and treatment

      EUROPEAN JOURNAL OF NEUROLOGY
    9. Mauclaire, L; Loc'h, C; Berthommier, E; Ottaviani, M; Boulanger, HD; Coulon, C; Maziere, B
      New preparation of (I-123) iodolisuride from the 2-tri-n-butylstannalisuride derivative

      NUCLEAR MEDICINE AND BIOLOGY
    10. Montastruc, JL; Rascol, O; Senard, JM
      Treatment of Parkinson's disease should begin with a dopamine agonist

      MOVEMENT DISORDERS
    11. Cannavo, S; Curto, L; Squadrito, S; Almoto, B; Vieni, A; Trimarchi, F
      Cabergoline: A first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    12. Appel, JB; West, WB; Rolandi, WG; Alici, T; Pechersky, K
      Increasing the selectivity of drug discrimination procedures

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    13. Rinne, UK
      Combination therapy with lisuride and L-dopa in the early stages of Parkinson's disease decreases and delays the development of motoric fluctuations.Longterm study over in years in comparison with L-dopa monotherapy

      NERVENARZT
    14. De Vries, P; De Visser, PA; Heiligers, JPC; Villalon, CM; Saxena, PR
      Changes in systemic and regional haemodynamics during 5-HT7 receptor-mediated depressor responses in rats

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    15. Matuszewich, L; Lorrain, DS; Trujillo, R; Dominguez, J; Putnam, SK; Hull, EM
      Partial antagonism of 8-OH-DPAT'S effects on male rat sexual behavior witha D-2, but not a 5-HMT1A, antagonist

      BRAIN RESEARCH
    16. Battistin, L; Bardin, PG; Ferro-Milone, F; Ravenna, C; Toso, V; Reboldi, G
      Alpha-dihydroergocryptine in Parkinson's disease: a multicentre randomizeddouble blind parallel group study

      ACTA NEUROLOGICA SCANDINAVICA
    17. Tesarova, E; Zaruba, K; Flieger, M
      Enantioseparation of semisynthetic ergot alkaloids on vancomycin and teicoplanin stationary phases

      JOURNAL OF CHROMATOGRAPHY A
    18. LANGE KW
      CLINICAL-PHARMACOLOGY OF DOPAMINE AGONISTS IN PARKINSONS-DISEASE

      Drugs & aging
    19. CLAUS JJ; DEKONING I; VANHARSKAMP F; BRETELER MMB; VOET B; GUTZMANN H; DAHLKE F; VANDERCAMMEN T; HOFMAN A
      LISURIDE TREATMENT OF ALZHEIMERS-DISEASE - A PRELIMINARY PLACEBO-CONTROLLED CLINICAL-TRIAL OF SAFETY AND THERAPEUTIC EFFICACY

      Clinical neuropharmacology
    20. POTTER DE; OGIDIGBEN MJ; CHU TC
      LISURIDE ACTS AT MULTIPLE SITES TO INDUCE OCULAR HYPOTENSION AND MYDRIASIS

      Pharmacology
    21. ONEILL MJ; HICKS CA; WARD MA; CARDWELL GP; REYMANN JM; ALLAIN H; BENTUEFERRER D
      DOPAMINE D-2 RECEPTOR AGONISTS PROTECT AGAINST ISCHEMIA-INDUCED HIPPOCAMPAL NEURODEGENERATION IN GLOBAL CEREBRAL-ISCHEMIA

      European journal of pharmacology
    22. CEJKA J; HORAK Z; PAKHOMOVA S; KRATOCHVIL B; SEDMERA P; HAVLICEK V; CVAK L; JEGOROV A
      SYNTHESIS AND CRYSTAL-STRUCTURE OF PERGOLIDE SULFOXIDE

      Collection of Czechoslovak Chemical Communications
    23. EGAN CT; HERRICKDAVIS K; MILLER K; GLENNON RA; TEITLER M
      AGONIST ACTIVITY OF LSD AND LISURIDE AT CLONED 5HT(2A) AND 5HT(2C) RECEPTORS

      Psychopharmacology
    24. LOSCHMANN PA; WULLNER U; HENEKA MT; SCHULZ JB; KUNOW M; WACHTEL H; KLOCKGETHER T
      DIFFERENTIAL INTERACTION OF COMPETITIVE NMDA AND AMPA ANTAGONISTS WITH SELECTIVE DOPAMINE D-1 AND D-2 AGONISTS IN A RAT MODEL OF PARKINSONS-DISEASE

      Synapse
    25. DUSKOVA J; POVYSIL C; SCHREIBER V
      AGNORS IN ESTROGEN-INDUCED AND LISURIDE-INHIBITED AND THYREOIDIN-INHIBITED RAT ANTERIOR-PITUITARY HYPERPLASIA - COMPUTER IMAGE-ANALYSIS ANDNONAUTOMATED AGNOR TYPING

      Analytical and quantitative cytology and histology
    26. ALLAIN H; BENTUEFERRER D
      INTERROGATIONS AND SOLUTIONS CONCERNING PARKINSONS-DISEASE

      La Presse medicale
    27. DELEU D; HANSSENS Y
      CURRENT AND EMERGING STRATEGIES IN THE MANAGEMENT OF PARKINSONS-DISEASE - A CRITICAL REAPPRAISAL

      Saudi medical journal
    28. TASDEMIR M; TASDEMIR S; TAVUKCUOGLU S; FICICIOGLU C
      RECTAL LISURIDE IN HYPERPROLACTINEMIC MEN

      Medical science research
    29. MULLER TH; EISING EG; REINERS C; PRZUNTEK H; JACOB M; KUHN W
      2-[I-123]-IODOLISURIDE SPET VISUALIZES DOPAMINERGIC LOSS IN DE-NOVO PARKINSONIAN-PATIENTS - IS IT A MARKER OF STRIATAL PRESYNAPTIC DEGENERATION

      Nuclear medicine communications
    30. INOUE K; KIRIIKE N; KURIOKA M; FUJISAKI Y; IWASAKI S; YAMAGAMI S
      BROMOCRIPTINE ENHANCES FEEDING-BEHAVIOR WITHOUT CHANGING DOPAMINE METABOLISM

      Pharmacology, biochemistry and behavior
    31. FERNANDEZGUASTI A; RODRIGUEZMANZO G
      8-OH-DPAT AND MALE-RAT SEXUAL-BEHAVIOR - PARTIAL BLOCKADE BY NORADRENERGIC LESION AND SEXUAL EXHAUSTION

      Pharmacology, biochemistry and behavior
    32. MEERT TF; ROMBOUTS J; VOETEN J; NARANJI F; CLINCKE G
      A SIMPLE, NONINVASIVE METHOD FOR THE MEASUREMENT OF RESERPINE-INDUCEDTREMOR IN RATS

      Acta Neurobiologiae Experimentalis
    33. FERRARI F; GIULIANI D
      INVOLVEMENT OF DOPAMINE D-2 RECEPTORS IN THE EFFECT OF COCAINE ON SEXUAL-BEHAVIOR AND STRETCHING-YAWNING OF MALE-RATS

      Neuropharmacology
    34. ANTKIEWICZMICHALUK L; ROMANSKA I; VETULANI J
      CA2-ACID DIETHYLAMIDE-INDUCED CHANGES IN DOPAMINE AND SEROTONIN METABOLISM( CHANNEL BLOCKADE PREVENTS LYSERGIC)

      European journal of pharmacology
    35. CALDWELL MA; REYMANN JM; ALLAIN H; LEONARD BE; BENTUEFERRER D
      LISURIDE PREVENTS LEARNING AND MEMORY IMPAIRMENT AND ATTENUATES THE INCREASE IN EXTRACELLULAR DOPAMINE-INDUCED BY TRANSIENT GLOBAL CEREBRAL-ISCHEMIA IN RATS

      Brain research
    36. TORUN S; ERDINC O
      SUPPRESSION OF PRIMARY WRITING TREMOR BY LISURIDE - A CASE-REPORT

      European journal of neurology
    37. UITTI RJ; AHLSKOG JE
      COMPARATIVE REVIEW OF DOPAMINE-RECEPTOR AGONISTS IN PARKINSONS-DISEASE

      CNS DRUGS
    38. BIER D; DUTSCHKA K; KNUST EJ
      RADIOCHEMICAL SYNTHESIS OF [I-123] 2-IODO-LISURIDE FOR DOPAMINE D2-RECEPTOR STUDIES

      Nuclear medicine and biology
    39. GIULIANI D; FERRARI F
      DIFFERENTIAL BEHAVIORAL-RESPONSE TO DOPAMINE D-2 AGONISTS BY SEXUALLYNAIVE, SEXUALLY ACTIVE, AND SEXUALLY INACTIVE MALE-RATS

      Behavioral neuroscience
    40. CALDWELL MA; REYMANN JM; BENTUEFERRER D; ALLAIN H; LEONARD BE
      THE DOPAMINE AGONISTS LISURIDE AND PIRIBEDIL PROTECT AGAINST BEHAVIORAL AND HISTOLOGICAL-CHANGES FOLLOWING 4-VESSEL OCCLUSION IN THE RAT

      Neuropsychobiology
    41. CORDES M; HIERHOLZER J; SCHELOSKY L; SCHRAG A; RICHTER WS; EICHSTADT H; SCHULZE PE; POEWE W; FELIX R
      IODINE-123-IODO-LISURIDE SPECT IN PARKINSONS-DISEASE

      The Journal of nuclear medicine
    42. FERRARI F; GIULIANI D
      BEHAVIORAL-EFFECTS INDUCED BY THE DOPAMINE D-3 AGONIST 7-OH-DPAT IN SEXUALLY-ACTIVE AND SEXUALLY-INACTIVE MALE-RATS

      Neuropharmacology
    43. SCHLEUSSNER E; DISTLER W
      TREATMENT OF ANOVULATION WITH ANTIESTROGE NS, PROLACTIN INHIBITORS, CORTICOSTEROIDS AND THYROID-HORMONES

      Der Gynakologe
    44. PACCHETTI C; ALBANI G; MARTIGNONI E; GODI L; ALFONSI E; NAPPI G
      OFF PAINFUL DYSTONIA IN PARKINSONS-DISEASE TREATED WITH BOTULINUM TOXIN

      Movement disorders
    45. FISCHER PA
      TREATMENT STRATEGIES IN PARKINSONS-DISEASE AFTER A QUARTER-CENTURY EXPERIENCES WITH L-DOPA THERAPY

      Journal of neural transmission. Supplementum
    46. PICCOLI F; RIUGGERI RM
      DOPAMINERGIC AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE - A REVIEW

      Journal of neural transmission. Supplementum
    47. RABEY JM
      2ND-GENERATION OF DOPAMINE AGONISTS - PROS AND CONS

      Journal of neural transmission. Supplementum
    48. AHLENIUS S; LARSSON K
      EFFECTS OF THE DOPAMINE D-3 RECEPTOR-LIGAND 7-OH-DPAT ON MALE-RAT EJACULATORY BEHAVIOR

      Pharmacology, biochemistry and behavior
    49. MIZUNO Y; KONDO T; NARABAYASHI H
      PERGOLIDE IN THE TREATMENT OF PARKINSONS-DISEASE

      Neurology
    50. AKAI T; OZAWA M; YAMAGUCHI M; MIZUTA E; KUNO S
      COMBINATION TREATMENT OF THE PARTIAL D-2 AGONIST TERGURIDE WITH THE D-1 AGONIST SKF-82958 IN ETHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-LESIONED PARKINSONIAN CYNOMOLGUS MONKEYS

      The Journal of pharmacology and experimental therapeutics
    51. SUNDARAM H; TURNER JD; STRANGE PG
      CHARACTERIZATION OF RECOMBINANT SEROTONIN 5-HT1A RECEPTORS EXPRESSED IN CHINESE-HAMSTER OVARY CELLS - THE AGONIST [H-3] LISURIDE LABELS FREE RECEPTOR AND RECEPTOR-COUPLED TO G-PROTEIN

      Journal of neurochemistry
    52. KRAUSE W; REISSMANN F; KUHNE G; SCHOBEL C
      CIRCADIAN PLASMA-LEVEL PROFILE OF LISURIDE IN RATS AND MICE AFTER CONTINUOUS ADMINISTRATION VIA THE DIET

      Arzneimittel-Forschung
    53. HIERHOLZER J; CORDES M; SCHELOSKY L; RICHTER W; SCHRAG A; POEWE W; SCHULZE PE; SEMMLER W; EICHSTADT H; FELIX R
      BRAIN SPECT WITH I-123 LISURID IN PATIENT S WITH PARKINSONS-DISEASE AND IN CONTROLS

      Nuklearmedizin
    54. MAY CH; GUILARTE TR; WAGNER HN; VOGEL S
      INTRASTRIATAL INFUSION OF LISURIDE - A POTENTIAL TREATMENT FOR PARKINSONS-DISEASE - BEHAVIORAL AND AUTORADIOGRAPHIC STUDIES IN 6-OHDA LESIONED RATS

      Neurodegeneration
    55. OBESO JA; GRANDAS F; HERRERO MT; HOROWSKI R
      THE ROLE OF PULSATILE VERSUS CONTINUOUS DOPAMINE-RECEPTOR STIMULATIONFOR FUNCTIONAL RECOVERY IN PARKINSONS-DISEASE

      European journal of neuroscience
    56. COLOSIMO C; MERELLO M; ALBANESE A
      CLINICAL USEFULNESS OF APOMORPHINE IN MOVEMENT-DISORDERS

      Clinical neuropharmacology
    57. AMINOFF MJ
      TREATMENT OF PARKINSONS-DISEASE

      Western journal of medicine
    58. DARMANI NA; MOCK OB; TOWNS LC; GERDES GF
      THE HEAD-TWITCH RESPONSE IN THE LEAST SHREW (CRYPTOTIS-PARVA) IS A 5-HT2-MEDIATED AND NOT A 5-HT1C-MEDIATED PHENOMENON

      Pharmacology, biochemistry and behavior
    59. PULVIRENTI L; KOOB GF
      LISURIDE REDUCES INTRAVENOUS COCAINE SELF-ADMINISTRATION IN RATS

      Pharmacology, biochemistry and behavior
    60. HUSAK M; KRATOCHVIL B; JEGOROV A; STUCHLIK J
      THE CRYSTAL AND MOLECULAR-STRUCTURE OF LISURIDE HYDROGEN MALEATE

      Zeitschrift fur Kristallographie
    61. FERRARI F; GIULIANI D
      EFFECT ON RAT-FEEDING BEHAVIOR OF 2 SELECTIVE D-2-DOPAMINE AGONISTS

      Physiology & behavior
    62. FERRARI F; GIULIANI D
      THE SELECTIVE D-2-DOPAMINE-RECEPTOR ANTAGONIST ETICLOPRIDE COUNTERACTS THE EJACULATIO-PRAECOX INDUCED BY THE SELECTIVE D-2-DOPAMINE AGONISTSND-919 IN THE RAT

      Life sciences
    63. GILLIN JC; PULVIRENTI L; WITHERS N; GOLSHAN S; KOOB G
      THE EFFECTS OF LISURIDE ON MOOD AND SLEEP DURING ACUTE WITHDRAWAL IN STIMULANT ABUSERS - A PRELIMINARY-REPORT

      Biological psychiatry
    64. PULVIRENTI L; KOOB GF
      LISURIDE REDUCES PSYCHOMOTOR RETARDATION DURING WITHDRAWAL FROM CHRONIC INTRAVENOUS AMPHETAMINE SELF-ADMINISTRATION IN RATS

      Neuropsychopharmacology
    65. MARRARI P; BASILEO G; PIANEZZOLA E; BENEDETTI MS
      DETERMINATION OF FCE 23884, A NEW ERGOLENE DERIVATIVE, AND ITS POSSIBLE METABOLITE, THE 6-NORDERIVATIVE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION

      Journal of pharmaceutical and biomedical analysis
    66. SCHWARZSTEIN D; GARCIAPATTERSON A; GIMENEZ G; CALAF J; PUIGDOMINGO M; CAIXAS A; MATIASGUIU X; WEBB SM
      DOPAMINERGIC RESISTANCE IN A CASE OF INVASIVE MACROPROLACTINOMA

      Journal of endocrinological investigation
    67. AKAI T; YAMAGUCHI M; MIZUTA E; KUNO S
      EFFECTS OF TERGURIDE, A PARTIAL D2 AGONIST, ON MPTP-LESIONED PARKINSONIAN CYNOMOLGUS MONKEYS

      Annals of neurology
    68. ROBLES RG; VILLA E; ANDRES A; MARTINEZ J; RUILOPE LM; SANCHO JM
      NATRIURETIC EFFECTS OF DOPAMINE AGONIST DRUGS IN MODELS OF REDUCED RENAL MASS

      Journal of cardiovascular pharmacology
    69. KRECZYKLEEDORFER B; WAGNER M; BOSCH S; POEWE W
      LONG-TERM FOLLOW-UP OF CONTINUOUS SUBCUTANEOUS APOMORPHINE PUMP TREATMENT IN PATIENTS WITH ADVANCED PARKINSONS-DISEASE

      Nervenarzt
    70. CALLAHAN PM; CUNNINGHAM KA
      DISCRIMINATIVE STIMULUS PROPERTIES OF COCAINE IN RELATION TO DOPAMINE-D(2) RECEPTOR FUNCTION IN RATS

      The Journal of pharmacology and experimental therapeutics
    71. MIZOKAWA T; AKAI T; NAKADA Y; YAMAGUCHI M; NAKAGAWA H; HASAN S; RETTIG KJ; WACHTEL H
      TERGURIDE AS A NEW ANTI-HYPERPROLACTINEMIC AGENT - CHARACTERIZATION IN RATS AND DOGS IN COMPARISON WITH BROMOCRIPTINE

      Japanese Journal of Pharmacology
    72. FERRARI F; GIULIANI D
      INFLUENCE OF IDAZOXAN ON THE DOPAMINE D(2) RECEPTOR AGONIST-INDUCED BEHAVIORAL-EFFECTS IN RATS

      European journal of pharmacology
    73. PAREDES RG; PINA AL; BERMUDEZRATTONI F
      HYPOTHALAMIC BUT NOT CORTICAL GRAFTS INDUCE RECOVERY OF SEXUAL-BEHAVIOR AND CONNECTIVITY IN MEDIAL PREOPTIC AREA-LESIONED RATS

      Brain research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 10:39:43